Glutathione S-transferase P1 single nucleotide polymorphism predicts permanent ototoxicity in children with medulloblastoma

Genetic variation in radiation and platinum pathways predicts severe acute radiation toxicity in patients with esophageal adenocarcinoma treated with cisplatin-based preoperative radiochemotherapy: results from the Eastern Cooperative Oncology Group

(2011) H. H. Yoon et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Ototoxicity: Mechanisms of Cochlear Impairment and its Prevention

(2011) K. Tabuchi et al.   CURRENT MEDICINAL CHEMISTRY

Ototoxicity After Intensity-Modulated Radiation Therapy and Cisplatin-Based Chemotherapy in Children With Medulloblastoma

(2010) Arnold C. Paulino et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Integrative Genomic Analysis of Medulloblastoma Identifies a Molecular Subgroup That Drives Poor Clinical Outcome

(2010) Yoon-Jae Cho et al.   JOURNAL OF CLINICAL ONCOLOGY

Medulloblastoma Comprises Four Distinct Molecular Variants

(2010) Paul A. Northcott et al.   JOURNAL OF CLINICAL ONCOLOGY

Association of single nucleotide polymorphisms in ATM, GSTP1, SOD2, TGFB1, XPD and XRCC1 with clinical and cellular radiosensitivity

(2010) Oliver Zschenker et al.   RADIOTHERAPY AND ONCOLOGY

Radiation Therapy for Pediatric Central Nervous System Tumors

(2009) Karen E. Hoffman et al.   JOURNAL OF CHILD NEUROLOGY

Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy

(2009) Colin J D Ross et al.   NATURE GENETICS

Risk analysis of severe myelotoxicity with temozolomide: The effects of clinical and genetic factors

(2009) Terri S. Armstrong et al.   NEURO-ONCOLOGY

Amifostine Protects Against Cisplatin-Induced Ototoxicity in Children With Average-Risk Medulloblastoma

(2008) Maryam Fouladi et al.   JOURNAL OF CLINICAL ONCOLOGY

Role of glutathione S-transferase P1-1 in the cellular detoxification of cisplatin

(2008) Christina Peklak-Scott et al.   MOLECULAR CANCER THERAPEUTICS

Glutathione S-transferase M1 and T1 polymorphisms may predict adverse effects after therapy in children with medulloblastoma

(2008) Nadia Barahmani et al.   NEURO-ONCOLOGY